Literature DB >> 10673961

Psycho-oncology: where have we been? Where are we going?

S Dolbeault1, A Szporn, J C Holland.   

Abstract

This article reviews the development of the subspeciality of psycho-oncology and its contributions to patient care, encouraging more attention to and research into the care of the total patient: the physical, psychological, social and spiritual aspects of care. The result is enhanced quality of life as the patient is studied in the domains of living that are important, extending across the continuum of care from diagnosis to palliative care. In addition, cancer prevention and early detection depends largely on changing attitudes and behaviours that put people at greater risk. This is an important area of research for psycho-oncologists. In the past two decades, research has contributed to our understanding of the psychological responses that accompany a cancer diagnosis. Oncologists better recognise psychological distress and psychiatric disorders such as anxiety, depression and delirium (in hospitalised patients) as frequent comorbid disorders. The development of valid assessment tools for the patients' self-report has been important. Increasingly, outcome measures in controlled trials of new therapies include quality of life, and no longer look at survival alone. The future will continue to bring new challenges to psycho-oncology as patients face new challenges in treatment. A major aim of the next century will be to bring this integrated approach to all patients in an affordable manner.

Entities:  

Mesh:

Year:  1999        PMID: 10673961     DOI: 10.1016/s0959-8049(99)00190-2

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  9 in total

1.  Quality of life in patients with head and neck cancers.

Authors:  Paul A Onakoya; Onyekwere G Nwaorgu; Adeniyi O Adenipekun; Akeem A Aluko; Titus S Ibekwe
Journal:  J Natl Med Assoc       Date:  2006-05       Impact factor: 1.798

2.  Noncancer life stresses in newly diagnosed cancer.

Authors:  Ulla-Sisko Lehto; Markku Ojanen; Anna Väkevä; Arpo Aromaa; Pirkko Kellokumpu-Lehtinen
Journal:  Support Care Cancer       Date:  2008-04-02       Impact factor: 3.603

3.  Burnout among psychosocial oncologists: an application and extension of the effort-reward imbalance model.

Authors:  Victoria Rasmussen; Adrienne Turnell; Phyllis Butow; Ilona Juraskova; Laura Kirsten; Lori Wiener; Andrea Patenaude; Josette Hoekstra-Weebers; Luigi Grassi
Journal:  Psychooncology       Date:  2015-08-04       Impact factor: 3.894

4.  Cancer-specific social support received by newly diagnosed cancer patients: validating the new Structural-Functional Social Support Scale (SFSS) measurement tool.

Authors:  Ulla-Sisko Lehto-Järnstedt; Markku Ojanen; Pirkko Kellokumpu-Lehtinen
Journal:  Support Care Cancer       Date:  2004-04-03       Impact factor: 3.603

5.  Marshalling Social Support: A "Care-Getting" Model for Persons Living with Cancer.

Authors:  Eva Kahana; Boaz Kahana; May Wykle; Diana Kulle
Journal:  J Fam Soc Work       Date:  2009-04-01

6.  Baseline psychosocial predictors of survival in localised breast cancer.

Authors:  U-S Lehto; M Ojanen; T Dyba; A Aromaa; P Kellokumpu-Lehtinen
Journal:  Br J Cancer       Date:  2006-05-08       Impact factor: 7.640

Review 7.  Psycho-oncology in Korea: past, present and future.

Authors:  Hyun Jeong Lee; Kwang-Min Lee; Dooyoung Jung; Eun-Jung Shim; Bong-Jin Hahm; Jong-Heun Kim
Journal:  Biopsychosoc Med       Date:  2017-05-01

8.  Early quality-of-life and psychological predictors of disease-free time and survival in localized prostate cancer.

Authors:  Ulla-Sisko Lehto; Markku Ojanen; Anna Väkevä; Tadeusz Dyba; Arpo Aromaa; Pirkko Kellokumpu-Lehtinen
Journal:  Qual Life Res       Date:  2018-12-03       Impact factor: 4.147

9.  A Comparative Study on Perceived Stress, Coping, Quality of Life, and Hopelessness between Cancer Patients and Survivors.

Authors:  Ottlingam Somasundaram Ravindran; Athira Shankar; Tejus Murthy
Journal:  Indian J Palliat Care       Date:  2019 Jul-Sep
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.